Detection of donor-specific antibodies in kidney transplantation

Kelley M.K. Haarberg, Anat R. Tambur

Research output: Contribution to journalArticlepeer-review

24 Scopus citations


Introduction Precise and timely detection of human leukocyte antigen (HLA) donor-specific antibodies (DSAs) is vital for evaluating humoral immune status of patients pre- and post-transplantation. Source of data Clinically relevant articles on theory, development, methodology and application of HLA-DSA testing in kidney transplantation. Areas of agreement and controversy The availability of solid phase HLA-antibody testing revolutionized our ability to detect HLA-DSA and to appreciate their significance in kidney transplant outcome. The best approach to determine the strength, immunogenicity and pathogenicity of HLA antibodies still remains controversial. Growing points Assays to identify complement-binding antibodies were developed. Their clinical utilization, pre- and post-transplantation, is currently under investigation. Appreciation of the complexity of HLA-DQ antibodies should lead to better assignment of unacceptable antibodies and cPRA calculation. Areas timely for developing research Characterization of HLA-antibody epitopes, and utilization of epitope matching to better define compatible donors could contribute to better transplant outcomes.

Original languageEnglish (US)
Pages (from-to)23-34
Number of pages12
JournalBritish Medical Bulletin
Issue number1
StatePublished - Jun 2014
Externally publishedYes


  • C1q
  • Complement-binding antibodies
  • Donor-specific antibodies
  • HLA-DQ antibodies
  • HLA-antibody epitope
  • Prozone
  • Solid-phase assays

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Detection of donor-specific antibodies in kidney transplantation'. Together they form a unique fingerprint.

Cite this